Mission Bay Capital

Profile

Mission Bay Capital is a venture capital firm based in the United States, focused on supporting the entrepreneurial efforts of scientists. They provide early-stage funding and operate from facilities that include an incubator to support startups right from the initial stages. Their co-working labs allow startups to begin operations quickly, helping them tackle major challenges like chronic diseases and environmental issues. They leverage a network of advisors, industry partners, and co-investors to support the growth of startups. The team is led by notable figures like Douglas Crawford, PhD, and Robert Blazej, PhD, who have extensive experience in both the scientific and business domains. The firm distinguishes itself by emphasizing early-stage innovations and facilitating efficient operations for startups through their facilities and network.

Mission Bay Capital focuses its investments primarily in the life sciences sector. They are known for taking on early-stage investments and providing vital resources for companies at a critical time. Their geographical focus is North America, supporting primarily Series A stage companies. They have formed strategic partnerships through their incubator, MBC BioLabs, which provides state-of-the-art facilities for young companies to conduct experiments. The firm manages fund vehicles like BioInnovation Capital, but specific financial details or AUM were not disclosed on the site.

Notable investments by Mission Bay Capital include Alector, Atreca, Cell Design Labs, iPierian, Mitokinin, and Redwood Biosciences. These companies have achieved significant milestones, including successful exits, and have made advancements in various medical and biotechnology areas. Their involvement with these companies underscores their commitment to fostering groundbreaking scientific innovations that address critical needs in the life sciences sector.